Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0U0SD
|
|||
| Drug Name |
RG-125
|
|||
| Synonyms |
AZD4076
Click to Show/Hide
|
|||
| Indication | Non-alcoholic fatty liver disease [ICD-11: DB92; ICD-10: K76.0; ICD-9: 571.8] | Phase 1 | [1] | |
| Company |
AstraZeneca Wilmington, DE Regulus Therapeutics San Diego, CA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.